Apr 04, 2023 4:05pm EDT iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
Jan 05, 2023 8:00am EST iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
Dec 05, 2022 8:00am EST iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022
